Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Cash Flows From Operating Activities:
Net loss	$ (5,968,086)	$ (9,460,888)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	309,684	268,595
Inventory write down	104,449
Amortization of debt discount	1,803,126	4,152,437
Addition of PIK monitoring fee to note payable	488,022
Change in fair value of foreign exchange contract derivative liability.	(489,435)	635,494
Change in fair value of warrant liability	(2,600,000)
Changes in operating assets and liabilities:
Prepaid expenses and other receivables, VAT receivable and deposit on foreign exchange deposit	1,113,853	(467,070)
Inventory	(2,021,130)	(864,636)
Accounts payable	25,842	34,897
Receivable/payable to related parties	(120,378)	75,977
Accrued expense and other liabilities	150,377	(167,568)
Deferred revenue		(297,419)
Net cash used in operating activities	(7,203,676)	(6,090,181)
Cash Flows From Investing Activities:
Capitalized patent costs		(135,168)
Capitalized software development costs		(27,879)
Purchase of property and equipment	(76,807)	(275,758)
Net cash used in investing activities	(76,807)	(438,805)
Cash Flows From Financing Activities:
Proceeds from issuance of common stock		696
Equity issuance cost paid		(273)
Proceeds from issuance of note payable	6,500,000	4,700,000
Principal payments on notes payable	(9,178,261)	(7,974,282)
Net cash used in financing activities	(2,678,261)	(3,273,859)
Net decrease in cash and restricted cash	(9,958,745)	(9,802,845)
Effect of exchange rate changes on cash and cash equivalents	(8,975)	(605,548)
Cash and cash equivalent at beginning of period	10,105,135	17,749,233
Cash, cash equivalent at end of period	137,416	7,340,840
Cash paid for:
Interest	921,000	1,522,372
Supplemental schedule of non-cash transactions:
Debt discount recognized upon issuance of notes payable	$ 1,310,000